- Home
- ASLE vs BWAY Comparison
ASLE vs BWAY Comparison
Compare ASLE & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- BWAY
- Stock Information
- Founded
- ASLE 2008
- BWAY 2003
- Country
- ASLE United States
- BWAY Israel
- Employees
- ASLE N/A
- BWAY N/A
- Industry
- ASLE Industrial Specialties
- BWAY Medical/Dental Instruments
- Sector
- ASLE Consumer Discretionary
- BWAY Health Care
- Exchange
- ASLE Nasdaq
- BWAY Nasdaq
- Market Cap
- ASLE 290.0M
- BWAY 280.7M
- IPO Year
- ASLE N/A
- BWAY 2019
- Fundamental
- Price
- ASLE $5.95
- BWAY $15.80
- Analyst Decision
- ASLE Hold
- BWAY Strong Buy
- Analyst Count
- ASLE 2
- BWAY 2
- Target Price
- ASLE $7.00
- BWAY $20.50
- AVG Volume (30 Days)
- ASLE 460.1K
- BWAY 71.2K
- Earning Date
- ASLE 11-06-2025
- BWAY 11-11-2025
- Dividend Yield
- ASLE N/A
- BWAY N/A
- EPS Growth
- ASLE N/A
- BWAY 189.46
- EPS
- ASLE 0.11
- BWAY 0.13
- Revenue
- ASLE $339,090,000.00
- BWAY $49,094,000.00
- Revenue This Year
- ASLE $9.98
- BWAY $335.63
- Revenue Next Year
- ASLE $8.15
- BWAY $22.10
- P/E Ratio
- ASLE $53.36
- BWAY $48.00
- Revenue Growth
- ASLE N/A
- BWAY 27.08
- 52 Week Low
- ASLE $5.56
- BWAY $7.84
- 52 Week High
- ASLE $9.12
- BWAY $17.92
- Technical
- Relative Strength Index (RSI)
- ASLE 22.00
- BWAY 44.42
- Support Level
- ASLE $5.86
- BWAY $14.75
- Resistance Level
- ASLE $6.20
- BWAY $16.63
- Average True Range (ATR)
- ASLE 0.24
- BWAY 0.67
- MACD
- ASLE -0.11
- BWAY -0.15
- Stochastic Oscillator
- ASLE 19.90
- BWAY 20.82
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.